Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

United Therapeutics completes enrollment in phase III pulmonary hypertension trial

Nov. 12, 1999

Synergistic effects Na+/H+ exchange inhibitor and K(ATP) channel opener in MI

Nov. 11, 1999

ELITE II fails to confirm results of ELITE; Merck drops HF indication for Cozaar

Nov. 11, 1999

Clinical results for Enbrel in heart failure presented at AHA Scientific Sessions

Nov. 11, 1999

Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA

Nov. 11, 1999

News from AHA: photoangioplasty with Antrin is safe and effective for PAD

Nov. 11, 1999

New HOPE for high-risk patients with cardiovascular disease

Nov. 11, 1999

Novel photosensitizer from Miravant prevents postangioplasty restenosis in pig model

Nov. 10, 1999

News from AHA: Bayer presents promising new treatment for atherosclerosis

Nov. 10, 1999

Vasopeptidase inhibitor steals the show at AHA

Nov. 10, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...